Tirzepatide is a GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity. Tirzepatide is a single peptide that triggers the body's receptors for GIP and GLP-1, two natural incretin hormones.
GIP has decreased food intake and increased energy expenditure, resulting in weight reductions. Combined with a GLP-1 receptor agonist, it has a more significant effect on glucose and body weight effects.
Substantial A1C reductions.
Boosted weight loss.
Improvements in cardiometabolic measures.
We offer a free pre-screening consult over the phone or via telemedicine to determine if peptide therapy would benefit you.
Life happens sometimes so if it is necessary to cancel or reschedule your scheduled appointment, we require that you let us know at least 48 hours' in advance of your scheduled appointment to avoid cancellation / rescheduling fees. Exceptions to this policy will be considered on a case by case basis.